Skip to main content
Veterinary Medicines

Kék Lukács kenőcs kutyák részére A.U.V.

Authorised
  • Azithromycin
  • Miconazole nitrate
  • Sulfamethoxazole

Product identification

Medicine name:
Kék Lukács kenőcs kutyák részére A.U.V.
Active substance:
  • Azithromycin
  • Miconazole nitrate
  • Sulfamethoxazole
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Azithromycin
    0.20
    milligram(s)
    /
    1.00
    gram(s)
  • Miconazole nitrate
    0.20
    milligram(s)
    /
    1.00
    gram(s)
  • Sulfamethoxazole
    28.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Ointment
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD06C
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Fortevit Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pernix Pharma Kft.
Responsible authority:
  • National Food Chain Safety Office
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 22/01/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 22/01/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 22/01/2024
How useful was this page?:
Average: 2 (6 votes)
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."